MedPath
HSA Approval

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

SIN10509P

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

December 5, 1998

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01XD01

metronidazole

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

METRONIDAZOLE

200 mg

Metronidazole

Documents

Package Inserts

1.4.3 Proposed Package Insert - Clean (230922).pdf

Approved: September 27, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL METRONIDAZOLE-200 TABLETS 200 mg - HSA Approval | MedPath